Impero (IMPERO) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Jul, 2026Executive summary
Achieved 24% year-over-year ARR growth to DKK 40.2M and 27% revenue growth to DKK 10.0M in Q1 2025, driven by platform investments and commercial expansion.
Maintained strong gross profit margin and improved cash flow from operating activities, with cash position at DKK 12.3M by end of Q1, despite negative EBITDA.
Churn rate reduced to 2% and net revenue retention rate improved to 110%.
Strategic focus on long-term value creation, platform innovation, and expansion into new geographies and channels.
Beta launch of Control Testing module and AI-driven compliance tools highlighted product innovation.
Financial highlights
Revenue for Q1 2025 was DKK 10.0M, up from DKK 7.8M in Q1 2024; gross profit reached DKK 9.7M with strong margin maintained.
EBITDA was negative at DKK -2.8M, compared to DKK -2.0M in Q1 2024.
Cash flow from operating activities improved to DKK 4.4M from DKK 2.5M in Q1 2024.
Operating loss (EBIT) was DKK -3.7M, compared to DKK -2.6M in Q1 2024.
Earnings per share (EPS) was DKK -0.16, compared to DKK -0.11 in Q1 2024.
Outlook and guidance
2025 ARR guidance set at DKK 46M–49M, representing 19%–27% growth.
EBITDA guidance for 2025 is DKK -10M to -8M, compared to DKK -8.7M in 2024.
Guidance assumes stable macroeconomic and geopolitical conditions, continued talent retention, and effective go-to-market execution.
Company aims to become cash flow positive before end of 2026.
Latest events from Impero
- Q2 brought a new administrator dashboard; control testing was targeted for end-July launch as an add-on.IMPERO
Investor update - 2025 brought faster releases and new control tools; entity-level governance and opt-in AI are next.IMPERO
Investor update - Reporting and control workflows expanded, with a control-testing add-on planned for mid-January 2025.IMPERO
Investor update - Control Health reveals activity friction as workflow, analytics and AI capabilities expand.IMPERO
Investor update - ARR up 24% to DKK 50.6M, EBITDA positive, and DACH region ARR grew 35% year-over-year.IMPERO
Q2 2026 - ARR up 15% to DKK 40.7M, revenue up 21%, EBITDA loss narrows, guidance maintained.IMPERO
Q2 2025 - 31% ARR growth, strong retention, and positive cash flow highlight robust Q3 performance.IMPERO
Q3 2024 - 28% ARR and 29% revenue growth, improved EBITDA, and strong DACH expansion in H1 2024.IMPERO
Q2 2024 - 28% ARR growth, improved EBITDA, and reduced churn set the stage for strong 2025 guidance.IMPERO
Q4 2024